Skip to main content
Erschienen in: Journal of Assisted Reproduction and Genetics 4/2018

08.02.2018 | Technological Innovations

Evaluation of extraction methods for methylated cell-free fetal DNA from maternal plasma

verfasst von: Ji Hyae Lim, Bom Yi Lee, Jin Woo Kim, You Jung Han, Jin Hoon Chung, Min Hyoung Kim, Dong Wook Kwak, So Yeon Park, Hee Back Choi, Hyun Mee Ryu

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Recently, fetal placenta-specific epigenetic regions (FSERs) have been identified for quantification of cell-free fetal DNA (cff-DNA) for non-invasive prenatal testing (NIPT). The aim of this study was to evaluate the efficiencies of a column-based kit and magnetic bead-based kit for quantification of methylated FSERs from maternal plasma.

Methods

Maternal plasma was extracted from normal pregnant women within the gestational age of 10~13 weeks (n = 24). Total cell-free DNA (cf-DNA) was extracted using a column-based kit and magnetic bead-based kit from the plasma of the same pregnant woman, respectively. Methylated FSERs were enriched from the extracted total cf-DNA using a methyl-CpG-binding domain-based protein method. The four FSERs were simultaneously quantified by multiplex real-time polymerase chain reaction.

Results

Methylated FSERs were detected in all samples extracted from both kits. However, the amplification of FSERs showed significant differences in the extraction efficiency of methylated FSERs between the two extraction methods. The Ct values of methylated FSERs extracted using the column-based kit were significantly lower than those obtained using the magnetic bead-based kit (P < 0.001 for all FSERs). The quantity of methylated FSERs was significantly higher for extracted DNA using the column-based kit than that extracted using the magnetic bead-based kit (P < 0.001 for all FSERs). Time and cost for the process of extraction were similar for the column kit and magnetic bead-based kit.

Conclusions

Our findings demonstrate that the column-based kit was more effective than the magnetic bead-based kit for isolation of methylated FSERs from maternal plasma as assessed by FSER detection.
Literatur
1.
Zurück zum Zitat Alberry M, Maddocks D, Jones M, Abdel Hadi M, Abdel-Fattah S, Avent N, et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn. 2007;27:415–8.CrossRefPubMed Alberry M, Maddocks D, Jones M, Abdel Hadi M, Abdel-Fattah S, Avent N, et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn. 2007;27:415–8.CrossRefPubMed
2.
Zurück zum Zitat Lun FM, Chiu RW, Chan KC, Leung TY, Lau TK, Lo YM. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem. 2008;54:1664–72.CrossRefPubMed Lun FM, Chiu RW, Chan KC, Leung TY, Lau TK, Lo YM. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem. 2008;54:1664–72.CrossRefPubMed
3.
Zurück zum Zitat Lo YM, Chan KC, Sun H, Chen EZ, Jiang P, Lun FM, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med. 2010;2:61ra91.CrossRefPubMed Lo YM, Chan KC, Sun H, Chen EZ, Jiang P, Lun FM, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med. 2010;2:61ra91.CrossRefPubMed
4.
Zurück zum Zitat Illanes S, Denbow M, Kailasam C, Finning K, Soothill PW. Early detection of cell-free fetal DNA in maternal plasma. Early Hum Dev. 2007;83:563–6.CrossRefPubMed Illanes S, Denbow M, Kailasam C, Finning K, Soothill PW. Early detection of cell-free fetal DNA in maternal plasma. Early Hum Dev. 2007;83:563–6.CrossRefPubMed
5.
6.
Zurück zum Zitat Norton ME, Brar H, Weiss J, Karimi A, Laurent LC, Caughey AB, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol. 2012;207:137.e1-8.CrossRefPubMed Norton ME, Brar H, Weiss J, Karimi A, Laurent LC, Caughey AB, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol. 2012;207:137.e1-8.CrossRefPubMed
7.
Zurück zum Zitat Old RW, Crea F, Puszyk W, Hultén MA. Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome. Reprod BioMed Online. 2007;15:227–35.CrossRefPubMed Old RW, Crea F, Puszyk W, Hultén MA. Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome. Reprod BioMed Online. 2007;15:227–35.CrossRefPubMed
8.
Zurück zum Zitat Papageorgiou EA, Fiegler H, Rakyan V, Beck S, Hulten M, Lamnissou K, et al. Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol. 2009;174:1609–18.CrossRefPubMedPubMedCentral Papageorgiou EA, Fiegler H, Rakyan V, Beck S, Hulten M, Lamnissou K, et al. Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol. 2009;174:1609–18.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Chu T, Burke B, Bunce K, Surti U, Allen Hogge W, Peters DG. A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease. Prenat Diagn. 2009;29:1020–30.CrossRefPubMed Chu T, Burke B, Bunce K, Surti U, Allen Hogge W, Peters DG. A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease. Prenat Diagn. 2009;29:1020–30.CrossRefPubMed
10.
Zurück zum Zitat Lee DE, Lim JH, Kim MH, Park SY, Ryu HM. Novel epigenetic markers on chromosome 21 for noninvasive prenatal testing of fetal trisomy 21. J Mol Diagn. 2016;18:378–87.CrossRefPubMed Lee DE, Lim JH, Kim MH, Park SY, Ryu HM. Novel epigenetic markers on chromosome 21 for noninvasive prenatal testing of fetal trisomy 21. J Mol Diagn. 2016;18:378–87.CrossRefPubMed
11.
Zurück zum Zitat Lui YY, Chik KW, Chiu RW, Ho CY, Lam CW, Lo YM. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex mismatched bone marrow transplantation. Clin Chem. 2002;48:421–7.PubMed Lui YY, Chik KW, Chiu RW, Ho CY, Lam CW, Lo YM. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex mismatched bone marrow transplantation. Clin Chem. 2002;48:421–7.PubMed
12.
Zurück zum Zitat Lim JH, Park SY, Ryu HM. Non-invasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood. Obstet Gynecol Sci. 2013;56:58–66.CrossRefPubMedPubMedCentral Lim JH, Park SY, Ryu HM. Non-invasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood. Obstet Gynecol Sci. 2013;56:58–66.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Tong YK, Jin S, Chiu RW, Ding C, Chan KC, Leung TY, et al. Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Clin Chem. 2010;56:90–8.CrossRefPubMed Tong YK, Jin S, Chiu RW, Ding C, Chan KC, Leung TY, et al. Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Clin Chem. 2010;56:90–8.CrossRefPubMed
14.
Zurück zum Zitat Papageorgiou EA, Karagrigoriou A, Tsaliki E, Velissariou V, Carter NP, Patsalis PC. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat Med. 2011;17:510–3.CrossRefPubMedPubMedCentral Papageorgiou EA, Karagrigoriou A, Tsaliki E, Velissariou V, Carter NP, Patsalis PC. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat Med. 2011;17:510–3.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Lim JH, Kim SY, Park SY, Lee SY, Kim MJ, Han YJ, et al. Non-invasive epigenetic detection of fetal trisomy 21 in first trimester maternal plasma. PLoS One. 2011;6:e27709.CrossRefPubMedPubMedCentral Lim JH, Kim SY, Park SY, Lee SY, Kim MJ, Han YJ, et al. Non-invasive epigenetic detection of fetal trisomy 21 in first trimester maternal plasma. PLoS One. 2011;6:e27709.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Lo YM, Lau TK, Zhang J, Leung TN, Chang AM, Hjelm NM, et al. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem. 1999;45:1747–51.PubMed Lo YM, Lau TK, Zhang J, Leung TN, Chang AM, Hjelm NM, et al. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem. 1999;45:1747–51.PubMed
17.
Zurück zum Zitat Zhong XY, Bürk MR, Troeger C, Jackson LR, Holzgreve W, Hahn S. Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat Diagn. 2000;20:795–8.CrossRefPubMed Zhong XY, Bürk MR, Troeger C, Jackson LR, Holzgreve W, Hahn S. Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat Diagn. 2000;20:795–8.CrossRefPubMed
18.
Zurück zum Zitat Farina A, LeShane ES, Lambert-Messerlian GM, Canick JA, Lee T, Neveux LM, et al. Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy. Clin Chem. 2003;49:239–42.CrossRefPubMed Farina A, LeShane ES, Lambert-Messerlian GM, Canick JA, Lee T, Neveux LM, et al. Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy. Clin Chem. 2003;49:239–42.CrossRefPubMed
19.
Zurück zum Zitat Lo YM. Fetal DNA in maternal plasma: progress through epigenetics. Ann N Y Acad Sci. 2006;1075:74–80.CrossRefPubMed Lo YM. Fetal DNA in maternal plasma: progress through epigenetics. Ann N Y Acad Sci. 2006;1075:74–80.CrossRefPubMed
20.
Zurück zum Zitat Lim JH, Park SY, Kim SY, Kim DJ, Choi JE, et al. Effective detection of fetal sex using circulating fetal DNA in first-trimester maternal plasma. FASEB J. 2012;26:250–8.CrossRefPubMed Lim JH, Park SY, Kim SY, Kim DJ, Choi JE, et al. Effective detection of fetal sex using circulating fetal DNA in first-trimester maternal plasma. FASEB J. 2012;26:250–8.CrossRefPubMed
21.
Zurück zum Zitat Shaw KJ, Thain L, Docker PT, Dyer CE, Greenman J, Greenway GM, et al. The use of carrier RNA to enhance DNA extraction from microfluidic-based silica monoliths. Anal Chim Acta. 2009;652:231–3.CrossRefPubMed Shaw KJ, Thain L, Docker PT, Dyer CE, Greenman J, Greenway GM, et al. The use of carrier RNA to enhance DNA extraction from microfluidic-based silica monoliths. Anal Chim Acta. 2009;652:231–3.CrossRefPubMed
Metadaten
Titel
Evaluation of extraction methods for methylated cell-free fetal DNA from maternal plasma
verfasst von
Ji Hyae Lim
Bom Yi Lee
Jin Woo Kim
You Jung Han
Jin Hoon Chung
Min Hyoung Kim
Dong Wook Kwak
So Yeon Park
Hee Back Choi
Hyun Mee Ryu
Publikationsdatum
08.02.2018
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 4/2018
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-018-1114-8

Weitere Artikel der Ausgabe 4/2018

Journal of Assisted Reproduction and Genetics 4/2018 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.